产品封面图

磷酸化α型-过氧化酶活化增生受体抗体

收藏
  • ¥1280
  • BIOSS
  • 北京
  • YS-4055R
  • 2025年08月20日
  • IHC-P=1:50-100 IHC-F=1:50-1421 (石蜡切片需做抗原修复) not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
  • rabbit
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      KLH conjugated synthetic peptide derived from human PRODH

    • 亚型

      IgG

    • 形态

      液态/冻干粉

    • 保存条件

      Store at -3314 °C

    • 克隆性

      多克隆

    • 宿主

      rabbit

    • 应用范围

      IHC-P=1:50-100 IHC-F=1:50-1421 (石蜡切片需做抗原修复) not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.

    • 浓度

      1mg/1ml

    • 规格

      0.2ml/0.1ML

    英文名称phospho-PPAR alpha (Ser12)
    中文名称磷酸化α型-过氧化酶活化增生受体抗体
    别 名PPAR alpha (phospho-Ser12); PPAR alpha (phospho-S12); p-PPAR alpha (Ser12); p-PPAR alpha (S12); hPPAR; MGC2237; MGC2452; NR1C1; Nuclear receptor subfamily 1 group C member 1; Peroxisome Proliferator Activated Receptor alpha; PPAR; PPAR alpha; PPARA; OTTHUMP00000197740; OTTHUMP00000197741; Peroxisome proliferator-activated receptor alpha; PPAR-alpha; PPARA_HUMAN; PPARalpha.
    规格100ul
    产品类型磷酸化抗体
    研究领域肿瘤 细胞生物 免疫学 转录调节因子 激酶和磷酸酶
    抗体来源Rabbit
    克隆类型Polyclonal
    交叉反应 Human, Mouse, Rat, Dog, Pig, Cow, Horse, Guinea Pig,
    产品应用WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 IF=1:100-500 (石蜡切片需做抗原修复)
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量52kDa
    细胞定位细胞核
    性 状Lyophilized or Liquid
    浓 度1mg/ml
    免 疫 原KLH conjugated Synthesised phosphopeptide derived from human PPAR alpha around the phosphorylation site of ser12:PL(p-S)PL
    亚 型IgG
    纯化方法affinity purified by Protein A
    储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
    PubMedPubMed
    产品介绍background:
    Peroxisome proliferators are nongenotoxic carcinogens which are purported to exert their effect on cells through their interaction with members of the nuclear hormone receptor family, termed Peroxisome Proliferator Activated Receptors (PPARs). Nuclear hormone receptors are ligand dependent intracellular proteins that stimulate transcription of specific genes by binding to specific DNA sequences following activation by the appropriate ligand. Studies indicate that PPARs are activated by peroxisome proliferators such as clofibric acid, nafenopin, and WY-14,643, as well as by some fatty acids. It has also been shown that PPARs can induce transcription of acyl coenzyme A oxidase and cytochrome P450 A6 (CYP450 A6) through interaction with specific response elements. PPAR alpha is activated by free fatty acids including linoleic, arachidonic, and oleic acids. Induction of peroxisomes by this mechanism leads to a reduction in blood triglyceride levels. PPAR alpha is expressed mainly in skeletal muscle, heart, liver, and kidney and is thought to regulate many genes involved in the beta-oxidation of fatty acids. Activation of rat liver PPAR alpha has been shown to suppress hepatocyte apoptosis. PPAR alpha, like several other nuclear hormone receptors, heterodimerizes with retinoic X receptor (RXR) alpha to form a transcriptionally competent complex.

    Function:
    Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety (By similarity). Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2.

    Subunit:
    Heterodimer; with RXRA. This heterodimerization is required for DNA binding and transactivation activity. Interacts with AKAP13, LPIN1 and PRDM16. Also interacts with PPARBP coactivator in vitro. Interacts with CITED2; the interaction stimulates its transcriptional activity (By similarity). Interacts with NCOA3 and NCOA6 coactivators. Interacts with ASXL1 AND ASXL2.

    Subcellular Location:
    Nucleus.

    Tissue Specificity:
    Skeletal muscle, liver, heart and kidney.

    Similarity:
    Belongs to the nuclear hormone receptor family. NR1 subfamily.
    Contains 1 nuclear receptor DNA-binding domain.

    SWISS:
    Q07869

    Gene ID:
    5465

    Database links:
    Entrez Gene: 5465 Human
    Entrez Gene: 19013 Mouse
    Entrez Gene: 25747 Rat
    Omim: 170998 Human
    SwissProt: Q07869 Human
    SwissProt: Q6I9S0 Human
    SwissProt: P23204 Mouse
    SwissProt: Q542P9 Mouse
    SwissProt: P37230 Rat
    Unigene: 103110 Human
    Unigene: 710044 Human
    Unigene: 212789 Mouse
    Unigene: 9753 Rat


    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    产品图片 产品细节图片1
    Sample:
    Liver (Rat) Lysate at 40 ug
    Primary: Anti-phospho-PPAR alpha (Ser12) (bs-4055R) at 1/300 dilution
    Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
    Predicted band size: 52 kD
    Observed band size: 52 kD

    产品细节图片2
    Sample:
    Heart (Mouse) Lysate at 40 ug
    Liver (Mouse) Lysate at 40 ug
    Primary: Anti-phospho-PPAR alpha (Ser12) (bs-4055R) at 1/300 dilution
    Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
    Predicted band size: 52 kD
    Observed band size: 52 kD

    产品细节图片3
    Sample:
    Colon carcinoma (Human) Lysate at 40 ug
    Embryo (Mouse) Lysate at 40 ug
    Primary: Anti- phospho-PPAR alpha (Ser12) (bs-4055R) at 1/300 dilution
    Secondary: HRP conjugated Goat-Anti-rabbit IgG (bs-0295G-HRP) at 1/5000 dilution
    Predicted band size: 52 kD
    Observed band size: 52 kD

    产品细节图片4
    Tissue/cell: rat kidney tissue; 4% Paraformaldehyde-fixed and paraffin-embedded;
    Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min;
    Incubation: Anti-phospho-PPAR alpha(Ser12) Polyclonal Antibody, Unconjugated(bs-4055R) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining

    产品细节图片5
    phosphopeptide non phosphopeptide

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    •  蛋白酪氨酸激酶

      ,广泛表达于多种组织细胞中)、erbB2/neu 及erbB-3基因表达产物。其家族成员的特点是在胞膜外有两个富含半胱氨酸的区域,胞浆内含有一个有酪氨酸激酶活化性的区域。 (2)胰岛素受体家族:其家族成员包括胰岛素受体(insulin receptor,IR)、胰岛素样生长因子-1受体(insulin-like growth factor-1receptor,IGF-1R)以及胰岛素相关受体(insulin related receptor,IRR)。胰岛素受体家族成员是由二个α亚单位和二

    • 糖原合成酶 glycogen synthase

         从 UDP葡萄糖把葡萄糖单位转移到直链的α( 1→ 4)葡聚糖上而合成糖原的酶, EC 2. 4. 1. 11。△ G0 ′ =-3千卡。糖原的α -( 1→ 6)键的生成由别种酶——糖原枝化酶进行。此酶的磷酸化( D,非活化)与磷酸化(Ⅰ活化)之间的相互转换是酶催化的, D酶是为 6-磷酸葡萄糖活化的变构酶。  

    • 光合作用基础知识讲座系列五:碳同化

      与CO2起羧化反应,推动C3碳循环,又能使RuBP与O2起加氧反应而引起C2氧化循环即光呼吸(见本节二。光呼吸)。羧化阶段分两步进行,即羧化和水解:在Rubisco作用下RuBP的C-2位置上发生羧化反应形成2-羧基-3酮基阿拉伯糖醇-1,5-二磷酸(2-carboxy-3-ketoarabinitol-1,5-bisphosphate, 3-keto-2CABP),它是一种与酶结合不稳定的中间产物,被水解后产生2分子PGA。Rubisco有活化与钝化两种形态,钝化酶可被CO2和Mg2+ 激活

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    上海古朵生物科技有限公司
    2025年07月12日询价
    询价
    上海研生实业有限公司
    2025年07月09日询价
    ¥1280
    优利科(上海)生命科学有限公司
    2025年07月14日询价
    ¥1536
    上海毕合生物化学技术有限公司
    2025年07月09日询价
    询价
    上海莼试生物技术有限公司
    2025年07月02日询价
    磷酸化α型-过氧化酶活化增生受体抗体
    ¥1280